Search clinical trials for: Ticagrelor + Aspirin

Total 1656 results

Juan J Badimon
AstraZeneca

Completed

Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

Coronary Artery Disease | Type-2 Diabetes Mellitus

United States
Beijing Tiantan Hospital

Not yet recruiting

Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke (TAPIS)

Ischemic Stroke, Acute
Ottawa Heart Institute Research Corporation

Suspended

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND (RAPID EXTEND)

Myocardial Infarction | Coronary Artery Disease

Canada
Icahn School of Medicine at Mount Sinai
AstraZeneca

Completed

Reversing Ticagrelor's Effects With Fresh Platelets

Coronary Artery Disease

United States
University of Florida
AstraZeneca

Active, not recruiting

Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus (OPTIMUS-7)

Coronary Artery Disease | Diabetes Mellitus, Type 2

United States
Assiut University

Unknown

Early Versus Late Loading of Ticagrelol in Patients With STEMI

Myocardial Infarction
Xijing Hospital

Active, not recruiting

1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon (CAGEFREEII)

Acute Coronary Syndrome | Angioplasty, Balloon | Antiplatelet Drug

China
The Catholic University of Korea
Chonnam National University Hospital

Completed

TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI

Acute Myocardial Infarction

Korea, Republic of
Beijing Tiantan Hospital
Ministry of Science and Technology of the People´s Republic of China

Completed

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II (CHANCE-2)

Stroke | Transient Ischemic Attack

China
Harbin Medical University
LanZhou University; Hebei General Hospital; The First Hospital of Jilin University and other collaborators

Active, not recruiting

EROSION II: OCT Guided PPCI in STEMI

ST-segment Elevation Myocardial Infarction

China
CeloNova BioSciences, Inc.
ClinLogix. LLC

Terminated

COBRA SHIELD OCT Study

Stable Angina

Finland
Jiangsu HengRui Medicine Co., Ltd.

Completed

To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects

Thrombosis

China
Zunyi Medical College

Recruiting

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

STEMI - ST Elevation Myocardial Infarction

China
University of Arkansas
American Society of Nephrology

Completed

Chronic Kidney Disease (CKD) Platelet Study

Chronic Kidney Diseases | Stroke, Ischemic | Heart Attack

United States
University of Athens

Completed

A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI (PTOLEMAIOS)

Aortic Valve Stenosis

Greece
Second Affiliated Hospital, School of Medicine,...

Recruiting

Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention (MATE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

China
Yonsei University

Recruiting

Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Acute Coronary Syndrome

Korea, Republic of
Xuanwu Hospital, Beijing

Recruiting

Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis (VISTA)

Ischemic Stroke | Vertebral Artery Stenosis

China
University of Florida
Medical University of South Carolina; National Institute of Neurological Disorders... and other collaborators

Recruiting

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)

Stroke | Intracranial Arteriosclerosis

United States
Seoul National University Hospital
B. Braun Korea Co., Ltd.

Completed

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial (HOST-IDEA)

Stable Angina | Unstable Angina | Non-ST Segment Elevation Myocardial Infarction

Korea, Republic of
Kafrelsheikh University
Ain Shams University

Completed

Ticagrelol Versus Aspirin in Ischemic Stroke

Ischemic Stroke | Acute Stroke

Egypt
The First Affiliated Hospital with Nanjing Medical...
National Natural Science Foundation of China

Completed

Reversal of the Anti-platelet Effects of Ticagrelor (REVERSAL)

Coronary Artery Disease

China
The Cleveland Clinic
AstraZeneca

Terminated

Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery (INTREPID)

Myocardial Injury

United States
Shenzhen Second People's Hospital

Not yet recruiting

the Safety and Efficacy of Antiplatelet Therapy in Patients of CAA

Cerebral Amyloid Angiopathy
Icahn School of Medicine at Mount Sinai

Completed

Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes

Type 2 Diabetes | Peripheral Artery Disease

United States
Nanjing First Hospital, Nanjing Medical University

Active, not recruiting

1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials

Coronary Artery Disease

China
Newcastle-upon-Tyne Hospitals NHS Trust
AstraZeneca; Newcastle University

Completed

Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Centro Cardiologico Monzino
IRCCS National Neurological Institute "C. Mondino" Foundation

Recruiting

Antiplatelet Therapies in Patients With Depression and Coronary Disease (ENHANCE)

Depression | Coronary Artery Disease

Italy
Clinical Centre of Serbia

Terminated

On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction (PLATFORM)

Acute ST-elevation Myocardial Infarction

Serbia
Chinese Academy of Medical Sciences, Fuwai Hospital

Completed

A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting (ATCCC)

Antiplatelet Therapy of Coronary Artery Bypass

China
Asan Medical Center

Recruiting

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent (OPTIMIZE-APT)

Coronary Artery Disease

Korea, Republic of
Ottawa Heart Institute Research Corporation

Terminated

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Percutaneous Coronary Intervention | Ticagrelor | Antiplatelet Therapy | Stable Coronary Syndrome

Canada
Deutsches Herzzentrum Muenchen
AstraZeneca

Terminated

Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG (TiCAB)

Coronary Artery Disease | Acute Coronary Syndrome | Stable Angina

Germany, Austria, Switzerland
Fujian Medical University

Recruiting

Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

Acute Coronary Syndrome | Percutaneous Coronary Intervention

China
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Multiple Myeloma and Plasma Cell Neoplasm

United States
Collegium Medicum w Bydgoszczy

Completed

Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study

Unstable Angina Pectoris

Poland
Federico II University
AdvicePharma Group

Completed

Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS (PlinytheElder)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | STEMI | NSTEMI

Italy
Collegium Medicum w Bydgoszczy
Medical Research Agency, Poland

Recruiting

Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome (ELECTRA-SIRIO)

Unstable Angina | STEMI | NSTEMI

Poland
University of Florida

Completed

High Ticagrelor Loading Dose in STEMI

Coronary Artery Disease

United States
University of Florida

Recruiting

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI (TAILOR BLEED)

Coronary Artery Disease

United States
Beijing Neurosurgical Institute

Completed

Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms (APISIA Trail)

Stents | Unruptured Intracranial Aneurysm | Antiplatelet Drugs

China
Xiaofan Wu

Unknown

Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation

Unstable Angina Pectoris | Coronary Stent Implantation

China
Juan J Badimon
AstraZeneca

Completed

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Acute Coronary Syndrome

United States
Second Affiliated Hospital, School of Medicine,...

Completed

Ticagrelor Versus Clopidogrel for CMD in Patients With AMI: A Retrospective Study Based on the Angio-IMR

Coronary Heart Disease

China
Chang Gung Memorial Hospital

Unknown

Post-operative Treatment of Diabetic Peripheral Arterial Disease Guided by Platelet Reactivity Unit

Peripheral Artery Disease
AstraZeneca
Parexel

Completed

A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Sickle Cell Disease

Germany
Assiut University

Unknown

Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI

ST Elevation Myocardial Infarction
The University of Hong Kong

Completed

Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS (FMD_ACS)

Acute Coronary Syndrome

China
AstraZeneca

Completed

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

Coronary Artery Disease

United States, United Kingdom
Dong-A University

Unknown

3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI (BULK-STEMI)

ST Elevation Myocardial Infarction

Korea, Republic of

Search clinical trials for: Ticagrelor + Aspirin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations